CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients
Trials of BiTEs for the treatment of acute leukemias
MURANO study: exciting times in CLL
Do CLL patients with mutated immunoglobulin receptors respond better to therapy?
How effective are monoclonal antibodies at improving overall survival?